Canada Pension Plan Investment Board
FOLD

Canada Pension Plan Investment Board’s Amicus Therapeutics FOLD Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.95M Sell
273,227
-12,500
-4% -$179K ﹤0.01% 800
2025
Q4 		$4.07M Buy
285,727
+81,600
+40% +$802K ﹤0.01% 818
2025
Q3 		$1.61M Sell
204,127
-314,373
-61% -$2.24M ﹤0.01% 943
2025
Q2 		$2.97M Buy
518,500
+369,800
+249% +$2.39M ﹤0.01% 794
2025
Q1 		$1.21M Buy
+148,700
New +$1.38M ﹤0.01% 885
2022
Q3 		– Sell
-10
Closed – – 1242
2022
Q2 		$0 Sell
10
-10,680
-100% -$88K ﹤0.01% 1309
2022
Q1 		$101K Sell
10,690
-11,956
-53% -$112K ﹤0.01% 1176
2021
Q4 		$262K Buy
22,646
+22,584
+36,426% +$252K ﹤0.01% 1198
2021
Q3 		$1K Sell
62
-2,715
-98% -$27.8K ﹤0.01% 1353
2021
Q2 		$27K Buy
2,777
+2,767
+27,670% +$27K ﹤0.01% 1095
2021
Q1 		$0 Sell
10
-1,350,600
-100% -$20.9M ﹤0.01% 1367
2020
Q4 		$31.2M Buy
1,350,610
+1,299,220
+2,528% +$26.6M 0.05% 294
2020
Q3 		$726K Sell
51,390
-334,610
-87% -$4.88M ﹤0.01% 784
2020
Q2 		$5.82M Buy
+386,000
New +$4.7M 0.01% 495
2019
Q3 		– Sell
-707,600
Closed -$8.83M – 1223
2019
Q2 		$8.83M Buy
+707,600
New +$8.98M 0.02% 580
2018
Q4 		– Sell
-266,600
Closed -$3.22M – 1306
2018
Q3 		$3.22M Buy
+266,600
New +$3.73M 0.01% 929
2017
Q3 		– Sell
-12,600
Closed -$127K – 1167
2017
Q2 		$127K Sell
12,600
-1,017,700
-99% -$8.19M ﹤0.01% 1049
2017
Q1 		$7.35M Buy
+1,030,300
New +$6.51M 0.02% 521
2014
Q2 		– Sell
-10,100
Closed -$21K – 1252
2014
Q1 		$21K Buy
+10,100
New +$25.3K ﹤0.01% 1229

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Canada Pension Plan Investment Board's FOLD Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Amicus Therapeutics (FOLD) stake by 4.4% in Q1 2026, selling an estimated $179K and leaving 273,227 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Canada Pension Plan Investment Board first reported a position in FOLD in Q1 2014 and has held it in 19 quarters since. The position peaked at $31.2M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Canada Pension Plan Investment Board held 273,227 shares of Amicus Therapeutics worth $3.95M as of Q1 2026.
  • Canada Pension Plan Investment Board sold 12,500 Amicus Therapeutics shares in Q1 2026, an estimated $179K.
  • Amicus Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #800 holding.
  • Canada Pension Plan Investment Board first reported a position in Amicus Therapeutics in Q1 2014 and has held it in 19 quarters since.
  • Canada Pension Plan Investment Board's Amicus Therapeutics position peaked at $31.2M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.